Trial comparing treatments for Duodenal Neoplasm
Official title Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
ClinicalTrials.gov ID: NCT06411795
What this study is testing
What is Bupivacaine?
Bupivacaine is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for duodenal neoplasm.
Also referred to as AH 250.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study wants to find out if a long-acting pain shot in the belly wall controls pain just as well as a traditional spinal pain pump after surgery.
- Who it's for
- The study is looking for people who are scheduled to have surgery to remove part of their pancreas and duodenum.
- What's involved
- Participants will receive either a pain shot in the abdominal muscles or a catheter in the spine to manage pain during and after the operation.
- Time commitment
- The study follows patients through their surgery and recovery period to monitor pain levels and side effects.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients, age 18 and older, undergoing open pancreaticoduodenectomy at the University of Minnesota will be included in the study
You likely can't join if
- Patients with contraindication to block placement (coagulopathy, local anesthetic allergy, infection)
- Patients with chronic opioid use (at least 30 milligram morphine equivalents [MME] for 3 or more weeks leading up to surgery)
- Patients unable to understand the quality of recovery survey intellectual barriers.
- Patient refusal and those who have opted out of research
- Pregnant patients - will be assessed through review of the medical record
The study team makes the final eligibility decision.
Where it is enrolling
- Minneapolis, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Minneapolis, Minnesota, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.